neonatal abstinence syndrome
neonatal abstinence syndrome
Explore linked clinical trials. Standard reference: MONDO:000556610 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Recorded Parent/Caregiver Voice for Infants With Neonatal Opioid Withdrawal Syndrome | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, neonatal abstinence syndrome, psychiatric disorder, substance-related disorder | Not yet recruiting | Not applicable | 2026-10-08 | NCT07864493 | |
| Effect of Music Therapy on Infants With Neonatal Abstinence Syndrome | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, neonatal abstinence syndrome, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-07-22 | NCT03533985 | |
| An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT) | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Narcotic-Related Disorders, Opioid Use Disorder, neonatal abstinence syndrome, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2026-07-06 | NCT06576323 | |
| Hepatic Energy Fluxes in NASH and NAS Patients | Body Weight, Body Weight Changes, Digestive System Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease, neonatal abstinence syndrome, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Not applicable | 2026-06-04 | NCT03997422 | |
| Neurostimulation to Improve NOWS Outcomes | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, neonatal abstinence syndrome, psychiatric disorder, substance withdrawal syndrome, substance-related disorder | Active, not recruiting | Not applicable | 2026-06-02 | NCT05129020 | |
| MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, neonatal abstinence syndrome, psychiatric disorder, substance-related disorder | Recruiting | Not stated | 2026-02-10 | NCT05937594 | |
| Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Narcotic-Related Disorders, neonatal abstinence syndrome, opiate dependence, psychiatric disorder, substance-related disorder | Active, not recruiting | Not applicable | 2026-02-05 | NCT04783558 | |
| The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, neonatal abstinence syndrome, psychiatric disorder, substance-related disorder | Recruiting | Not applicable | 2025-09-17 | NCT05226624 | |
| Study to Collect Data for Neonatal Abstinence Syndrome (NAS) and Evaluate the Automated Data Collection Process | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, neonatal abstinence syndrome, psychiatric disorder, substance-related disorder | Enrolling by invitation | Not stated | 2025-09-09 | NCT06303986 | |
| Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, neonatal abstinence syndrome, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 4 | 2024-10-15 | NCT03092011 |